BioCentury
ARTICLE | Clinical News

CAT-1004: Phase I data

February 18, 2013 8:00 AM UTC

A 3-part, double-blind, placebo-controlled, U.S. Phase I trial in 105 healthy volunteers or Type II diabetics showed that oral CAT-1004 was well tolerated. Additionally, a single dose of CAT-1004 in h...